Market
BSE Prices delayed by 5 minutes... << Prices as on Apr 21, 2026 - 3:59PM >>  ABB India  7247 [ 1.28% ] ACC  1438 [ 0.59% ] Ambuja Cements  456.35 [ 0.41% ] Asian Paints  2545.9 [ 1.18% ] Axis Bank  1377 [ 1.72% ] Bajaj Auto  9792.2 [ -0.03% ] Bank of Baroda  284.1 [ 1.16% ] Bharti Airtel  1854.8 [ 0.53% ] Bharat Heavy  332.7 [ 2.18% ] Bharat Petroleum  318.05 [ 0.65% ] Britannia Industries  5844 [ 2.50% ] Cipla  1232.6 [ 0.30% ] Coal India  442.8 [ 0.26% ] Colgate Palm  2113 [ -0.79% ] Dabur India  453.25 [ 2.49% ] DLF  609 [ 2.21% ] Dr. Reddy's Lab.  1220 [ -0.99% ] GAIL (India)  160.8 [ 1.97% ] Grasim Industries  2784.3 [ 0.97% ] HCL Technologies  1441.55 [ 0.92% ] HDFC Bank  811.65 [ 2.04% ] Hero MotoCorp  5267.45 [ -0.27% ] Hindustan Unilever  2305.4 [ 3.13% ] Hindalco Industries  1021.7 [ 0.65% ] ICICI Bank  1388.65 [ 2.41% ] Indian Hotels Co.  666.4 [ 1.35% ] IndusInd Bank  856.45 [ 0.51% ] Infosys  1313.1 [ 0.09% ] ITC  309.15 [ 1.36% ] Jindal Steel  1285.1 [ -0.18% ] Kotak Mahindra Bank  381.5 [ 0.61% ] L&T  4075.75 [ 0.64% ] Lupin  2305 [ -1.01% ] Mahi. & Mahi  3249 [ 0.91% ] Maruti Suzuki India  13450 [ 0.03% ] MTNL  32.15 [ -0.34% ] Nestle India  1378.7 [ 7.09% ] NIIT  71 [ -0.64% ] NMDC  88.45 [ -0.41% ] NTPC  396.1 [ -0.45% ] ONGC  283.05 [ -0.11% ] Punj. NationlBak  114.1 [ 0.31% ] Power Grid Corpn.  318.35 [ -0.39% ] Reliance Industries  1353.65 [ -0.66% ] SBI  1112.15 [ 0.41% ] Vedanta  767.05 [ -0.47% ] Shipping Corpn.  300.9 [ 0.20% ] Sun Pharmaceutical  1665.7 [ -0.14% ] Tata Chemicals  707.7 [ 0.52% ] Tata Consumer  1144 [ 2.26% ] Tata Motors Passenge  356.05 [ 0.13% ] Tata Steel  211.8 [ 0.07% ] Tata Power Co.  435.7 [ 0.47% ] Tata Consult. Serv.  2610.55 [ 1.24% ] Tech Mahindra  1500.35 [ -0.25% ] UltraTech Cement  12032.2 [ 1.02% ] United Spirits  1358.9 [ 3.99% ] Wipro  205.05 [ 1.31% ] Zee Entertainment  86.75 [ -1.08% ] 
Deep Health AI India Ltd. Notes to Accounts
Search Company 
You can view the entire text of Notes to accounts of the company for the latest year
Market Cap. (Rs.) 34.02 Cr. P/BV 0.88 Book Value (Rs.) 2.67
52 Week High/Low (Rs.) 10/2 FV/ML 1/1 P/E(X) 38.82
Bookclosure 07/11/2025 EPS (Rs.) 0.06 Div Yield (%) 0.00
Year End :2025-03 

The Rights, powers and preferences relating to each class of share capital and the qualifications, limitations and restrictions thereof are contained in the Memorandum and Articles of Association of the Company. The principle rights are as follows :

Equity Shares of Rs. 1/- each The Company has only one class of share capital namely Equity shares having a face value of Rs. 1/- per share.

a. In respect of every Equity Share (whether fully paid or partly paid),voting right shall be in the same proportion as the capital paid up on such Equity Share bears to the total paid up Equity capital of the Company

During the year ended 31st March 2025, the amount of per share dividend recognized as distributions to equity shareholders was

24. Contingent Liabilities (IndAS37)

Contingent Liabilities Not Provided For :-31/03/2025

a) Estimated amount of contracts remaining to be

executed on capital account NIL

b) Claims against company not acknowledged as debts NIL

25. OTHER NOTES :

i) Foreign Exchange earnings and out-go is Rs. NIL

26. Related Party Disclosure (Ind AS 24)

Disclosure requirements as per (Ind AS 24)" Related Party Disclosure" issued by the Institute of Chartered Accountants of India

I. List of Related Parties : Name of Related Parties and nature of relationships :

A. Key Managerial Personnel

• Mr. Narayan Singh Rathore - Managing Director appointed on 11.04.2025

• Mr. Narendra Kumar Shrimali - Director

• Mr. Rajesh Pherwani - Director

• Miss Laveena Pokharna-CFO and Whole Time Director appointed on 11.04.2025

• Mr. Prashant Tali - Company Secretary

• Mr. Kailash Chandra - Director

• Mr. Kaushal Jain - Director

• Ganpat Lal Nyati - Director till 30.11.2024

Sonali Laddha - Director till 31.10.2024

Subsidiary Entity

• Mircocure Biotech Private Limited

B. Associate Enterprises

• Ferry Automotive Private Limited

C. Joint Venture

• Hemonc Pharma Private Limited

D. Other Related Parties - NIL

28. Segment Reporting (IndAS -108)

The Company is responsible for Segment reporting as per IndAS -108 "Operating Segment" specified under section 133 of the Companies Act, 2013. As the Company is engaged in two segment viz. Jewellery of Gold and Diamond Studded and Marketing of Pharmaceutical goods in India,

29. Deferred taxes on Income (IndAS 12):-

The company is entitled to create deferred tax asset in the books of A/cs with respect to timing difference of carried forward Capital Loss as well as depreciation.

30.In the absence of confirmation from some of the parties and pending reconciliation the debit and credit balances with regard to recoverable and payable have been taken as reflected in the books. In the opinion of the Directors, Loans and Advances and Current Assets, if realized in the ordinary course of business, have the value at which they are stated in the Balance Sheet.

23. Earnings Per Share (IndAS 33)

As per (IndAS 33) "Earning Per Share'' issued by Institute of Chartered Accountant of India the Company gives following disclosure for the year.

32. Financial Risk Management Objective & Policies

This section gives an overview of the significance of financial instruments for the Company and provides additional information on the balance sheet. Details of significant accounting policies, including the criteria for recognition, the basis of measurement and the basis on which income

and expenses are recognised, in respect of each class of financial assets and financial liabilities are disclosed.

The management has assessed that the fair value of current and non-current loan and advances, other non-current asset, trade receivables approximate their carrying amounts largely due to the short term maturities of these instruments.

The fair value of Investmentsare based on the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate the fair values:

1) The fair values of the quoted equity shares are based on price quotations at the reporting date.

2) Investment in Subsidiary and Associate Companies are carried at cost.

3) The fair values of the unquoted debentures, mutual fund and equityshares have been estimated using Net Asset Value (NAV) as at reporting date.

The valuation of unquoted equity shares requires management to make certain assumptions about the Model Inputs, including forecast of cash flows, discount rate, credit risk and volatility. The probabilities of the various estimates within range can be reasonably assessed and are used in management's estimate of fair value for these unquoted shares. Wherever, the probability is low, valuation has been done based on redemption assumptions.

Fair Value Hierarchy

The different levels have been defined below:

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities

Level 2: inputs other than quoted prices included within Level 1 that are observable for the

asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices)

Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs)

33. Ratio Analysis

The table for ratio analysis is enclosed below in Annexure A

34. Other Statutory Information

I. The company has not traded or invested in crypto currency or virtual currency during the financial year.

II. As per information available, the company has no transactions which are not recorded in the books of accounts and which are surrendered or disclosed as income during the year in the tax assessment or in search or survey or under any other relevant provisions of the Income Tax Act, 1961.

III. The company is not covered under the requirements of Section 135 of the Companies Act, 2013, with respect to the CSR activities.

IV. The company is holding all the immovable properties in its own name as investment.

V. The company do not hold any benami property and no proceedings has been initiated or pending against the company for holding any benami property under Benami Transactions (Prohibition) Act 1988 and rules made there under

VI. The company has not been declared as willful defaulter by any bank or financial Institution or any other lender during the year.

VII. The company do not had any transactions during the year with the companies which are struck off under section 248 of the companies Act 2013 or section 560 of the companies Act 1956.

VIII. The company does not have any charge which are required to be registered with ROC under the terms of the loans & liabilities.

IX. As per the information & details available on records and the disclosure given by the management, the company has complied with the number of layers prescribed under clause (87) of section 2 of the companies Act read with the Companies (Restriction on number of layers) Rules 2017.

35. The figures for the previous year have been regrouped / rearranged / reclassified wherever necessary.


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by